Cargando…
Network Pharmacology-Based Exploration on the Intervention of Qinghao Biejia Decoction on the Inflammation-Carcinoma Transformation Process of Chronic Liver Disease via MAPK and PI3k/AKT Pathway
Chronic liver disease(CLD) is a slow-developing and long-term disease that can cause serious damage to the liver. Thus far, it has been associated with viral hepatitis, non-alcoholic fatty liver disease(NAFLD), alcoholic liver disease(ALD), hepatic fibrosis(HF), liver cirrhosis (LC), and liver cance...
Autores principales: | Cheng, Xin, Han, Zhong-Xiao, Su, Zi-Jie, Zhang, Feng-Lin, Li, Biao-Ping, Jiang, Zhi-Rui, Tang, Ling, Yang, Jia-Shun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9586778/ https://www.ncbi.nlm.nih.gov/pubmed/36277879 http://dx.doi.org/10.1155/2022/9202128 |
Ejemplares similares
-
Efficacy and Safety of Qinghao Biejia Decoction in the Treatment of Systemic Lupus Erythematosus: A Systematic Review and Meta-Analysis
por: Li, Xiaobo, et al.
Publicado: (2021) -
Integrating Network Pharmacology and Experimental Validation to Explore the Effects and Mechanisms of Qinghao Biejia Decoction and Its Active Compound Artemisinin B Against Non-Small-Cell Lung Cancer
por: Ye, Yonghua, et al.
Publicado: (2023) -
Qinghao-Biejia Herb Pair Alleviates Pristane-Induced Lupus-Like Disease and Associated Renal and Aortic Lesions in ApoE(−/−) Mice
por: Hong, Jiaze, et al.
Publicado: (2022) -
Evaluation of the efficacy of Biejia decoction pill combined with entecavir in the treatment of hepatitis B liver fibrosis/cirrhosis by VCTE
por: Wan, Lijun, et al.
Publicado: (2023) -
The Biosynthesis of Artemisinin (Qinghaosu) and the Phytochemistry of Artemisia annua L. (Qinghao)
por: Brown, Geoffrey D.
Publicado: (2010)